Does RANIBIZUMAB Cause Maculopathy? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Maculopathy have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.3% of all adverse event reports for RANIBIZUMAB.
46
Reports of Maculopathy with RANIBIZUMAB
0.3%
of all RANIBIZUMAB reports
2
Deaths
5
Hospitalizations
How Dangerous Is Maculopathy From RANIBIZUMAB?
Of the 46 reports, 2 (4.3%) resulted in death, 5 (10.9%) required hospitalization.
Is Maculopathy Listed in the Official Label?
Yes, Maculopathy is listed as a known adverse reaction in the official FDA drug label for RANIBIZUMAB.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Maculopathy?
PENTOSAN POLYSULFATE (1,389)
HYDROXYCHLOROQUINE (227)
SERTRALINE (79)
METHOTREXATE (69)
TOPIRAMATE (47)
TAMOXIFEN (42)
SILDENAFIL (37)
ADALIMUMAB (36)
FINGOLIMOD (34)
TRIAMCINOLONE ACETONIDE (31)
Which RANIBIZUMAB Alternatives Have Lower Maculopathy Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE